Bausch Health Companies Inc. Common Stock (NYSE: BHC)
The Complaint alleges that Defendants made false and/or misleading statements about the Company’s spinoff of the Bausch + Lomb Corporation, including the benefits it would provide for Bausch shareholders and the effects it would have on Bausch post-spinoff. The Complaint also alleges that the spinoff was done not to benefit shareholders but instead to undermine plaintiff lawsuits stemming from securities laws violations in 2016.